The binding of ISM and GRP78 creates a complex that exerts proapoptotic effects in activated endothelial and cancer cells expressing high levels of GRP78, thereby inhibiting tumor progression and angiogenesis. This evidence concerns the gene HSPA5 and neoplasm.